The joint statement in response to the publication of the Initiative praises it as a positive starting point, while calling for greater ambition and implementation. The initiative recognizes various challenges and barriers, including the need for a level playing field for market entry and demand. A key step in addressing these issues is streamlining and ...
IPA Europe is advocating for European policymakers to reassess the criteria governing the term ‘probiotic’ for food and food supplements within the EU. The current regulatory framework dates back to 2007, placing European stakeholders at a competitive disadvantage. Read our statement published in the April edition of ‘The Parliament Magazine’ for further insight. Read more ...
Brussels, 22 February 2024 Cross sectoral industries have come together to champion the European Commission’s forthcoming Biotechnology and Biomanufacturing Initiative through a position paper which calls for bold ambition, and five core principles to ensure impactful industrial growth. The ‘EC Initiative on Biotechnology and Biomanufacturing: Principles for an impactful Europe’ calls for the recognition of ...
IPA Europe, representing probiotic food and food supplements in Europe, is pleased to announce the election for the new President, Dr. Bart Degeest, during the Board meeting of the association held in Milan. Dr. Degeest has consistently demonstrated a profound understanding of the challenges andopportunities facing our community and contributes to various strategic teams. In ...
Brussels, 11 September 2023 The International Probiotic Association (IPA & IPAEurope) is returning with the 3rd Science & Business Symposium during the 12th Probiotic, Prebiotics, and New Food Congress (Rome 16-19 September 2023) IPA with IPAEurope is returning with the 3rd Science & Business Symposium during the 12th Probiotic, Prebiotics, and New Food event in ...
“How can better regulation strengthen the knowledge of probiotics for consumer health?” The virtual conference on 24th April 2023 featured an opening debate on the science of probiotics, the lack of regulation and how greater clarity can benefit the European industry while providing better information and transparency to consumers. PRESS-RELEASE – EURACTIV online conference.pdf ...
Speaking at IPA Probiota World Congress in Barcelona on 8 February 2023, Rosanna Pecere, Executive Director of IPA Europe, presented the overview of the European market ‘It is not only “in some third countries” that the use of the term ‘probiotics’ may be regulated differently’ she said. Since 2018, some EU countries are progressively allowing the ...
The ongoing popularity of the use of probiotics across Europe highlights the importance of a EU harmonised criteria of ‘probiotic’ definition. Clarifying the definition of the term ‘probiotic’ at European level would enhance the competitiveness of European companies, while providing clearer and more transparent information to consumers. read the article published by IDM. Link to ...
Background: Irritable bowel syndrome (IBS) is a chronic and often debilitating disorder of gut-brain interaction (DGBI), formerly known as functional gastrointestinal disorder. Experts from 7 Italian Societies conducted a Delphi consensus with a literature summary and a voting process on 27 statements. About probiotics: The results of meta-analysis and RCTs suggest that probiotics as a group may be ...
Based on the existing literature, oral probiotics may be beneficial in children with asthma. However, the duration of treatments, entities evaluated, strains used, and characteristics of enrolled subjects vary across studies. The choice of probiotics (strain-specific) should be based on documented evidence. Research implies that probiotics have a role in rebalancing the immune response, repairing ...